Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug remdesivir for use in COVID-19 patients, a top Mexican health official said on Friday.
FILE PHOTO: An ampule of Gilead Sciences COVID-19 antiviral remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease continues. Ulrich Perrey/Pool via REUTERS/File Photo
Mexico’s health regulator Cofepris has already twice denied approval for the drug with a “non-favorable” opinion, deputy health minister Hugo Lopez-Gatell told his regular nightly news conference. The FDA approved remdesivir on Thursday, making it the first and only drug approved for the disease in the United States.
The World Health Organization’s Solidarity drug trial last week concluded remdesivir has little or no impact on a patient’s chances of surviving COVID-19, and a top WHO scientist on Friday recommended the FDA consider all available evidence.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA COVID-19 Vaccine Process Is 'Thoughtful And Deliberate,' Says Former FDA HeadRachel Martin speaks with former Food and Drug Administration commissioner Dr. Mark McClellan about this week's FDA advisory panel on COVID-19 vaccine research.
Read more »
Will FDA Heed Its Outside Experts' Advice On COVID-19 Vaccines?A panel of doctor and scientists raised questions about the expedited regulatory path the Food and Drug Administration is considering for COVID-19 vaccines.
Read more »
FDA approves remdesivir as treatment for COVID-19 patients in hospitalThe Food and Drug Administration on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.
Read more »
COVID Vaccine Standards Questioned at FDA MeetingResearchers and several medical groups on Thursday pressed for changes to the FDA’s plans for deciding how to eventually approve vaccines for COVID-19, arguing tougher standards would help bolster confidence in these critical medicines.
Read more »
FDA Approves Remdesivir For Covid-19 TreatmentThe FDA approved remdesivir as a treatment for hospitalized coronavirus patients by rachsandl
Read more »
Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.
Read more »